USP5 and neoplasm: We conducted extensive structure-activity relationship studies on WP1130, a Usp5/Usp9x/Usp14/UCH-L1/UCH-L5 inhibitor [22, 29], to improve its safety, solubility and anti-tumor activity in mice.